Contrast Media (CM), Magnetic Resonance Imaging (MRI), Interventional Radiology (IRT), Imaging Solution and Services (ISS)
Since 1926, the Guerbet group has had a long-standing tradition as a pioneer in the research and development of medical imaging contrast media. Headquartered in Paris, France, Guerbet is a publicly traded company holding more than 25% of the European market share and 7% of the worldwide contrast media market. Guerbet makes full use of its know-how and innovative capacity to meet the major public health challenges of the 21st century. Guerbet's men and women are committed to offering health professionals contrast agents, medical devices and innovative solutions indispensable to diagnostic and interventional imaging to improve patients' prognosis and quality of life. Affiliated to Guerbet Asia Pacific, Guerbet Shanghai is specialized in providing medical consulting services.
Medical Consulting service related to pharmatheutical / medical devices etc.
Our brands include:
- CT & Cathlab contrast media: OptiRAY®,
- MRI contrast media: Dotarem®,
- Interventional Imaging solution: Lipiodol®
- LF Injectors: OptiOne®, OptiVantage®, OptiStar® Elite, Angiomate® Illumena®